Heron Therapeutics Announces U.S. FDA Approval of SUSTOL® (granisetron) Extended-Release Injection for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Go back to Heron Therapeutics Announces U.S. FDA Approval of SUSTOL® (granisetron) Extended-Release Injection for the Prevention of Chemotherapy-Induced Nausea and Vomiting| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 0.27 -0.04 (12.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.31 | 52 Week High | $31.32 | |||
| Open | $0.31 | 52 Week Low | $13.95 | |||
| Day High | $0.31 | P/E | N/A | |||
| Day Low | $0.26 | EPS | $-3.29 | |||
| Volume | 8,585,587 | |||||
